Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 30 Records) |
| Query Trace: Neoplasms and UGT2B15[original query] |
|---|
| An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Annals of surgical oncology 2000 Dec 7 (10): 777-82. MacLeod S L, Nowell S, Plaxco J, Lang N |
| UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast cancer research : BCR 2004 6 (5): R488-98. Sparks Rachel, Ulrich Cornelia M, Bigler Jeannette, Tworoger Shelley S, Yasui Yutaka, Rajan Kumar B, Porter Peggy, Stanczyk Frank Z, Ballard-Barbash Rachel, Yuan Xiaopu, Lin Ming Gang, McVarish Lynda, Aiello Erin J, McTiernan An |
| Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. The Journal of urology 2004 Jun 171 (6 Pt 1): 2484-8. Park Jong, Chen Lan, Shade Kristin, Lazarus Philip, Seigne John, Patterson Stephen, Helal Mohamed, Pow-Sang Jul |
| Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score. The Prostate 2004 Jun 59 (4): 436-9. Hajdinjak T, Zagradisnik B |
| Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast cancer research and treatment 2005 Jun 91 (3): 249-58. Nowell Susan A, Ahn Jiyoung, Rae James M, Scheys Joshua O, Trovato Andrew, Sweeney Carol, MacLeod Stewart L, Kadlubar Fred F, Ambrosone Christine |
| Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population. Cancer detection and prevention 2006 30 (3): 262-8. Okugi Hironobu, Nakazato Haruki, Matsui Hiroshi, Ohtake Nobuaki, Nakata Seiji, Suzuki Kazuhi |
| Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 May 16 (5): 969-78. Cunningham Julie M, Hebbring Scott J, McDonnell Shannon K, Cicek Mine S, Christensen G Bryce, Wang Liang, Jacobsen Steven J, Cerhan James R, Blute Michael L, Schaid Daniel J, Thibodeau Stephen |
| Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer. Breast cancer research : BCR 2007 9 (1): R7. Wegman Pia, Elingarami Sauli, Carstensen John, Stål Olle, Nordenskjöld Bo, Wingren St |
| The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness. Cancer prevention research (Philadelphia, Pa.) 2011 Dec 4 (12): 2044-50. Sun Tong, Oh William K, Jacobus Susanna, Regan Meredith, Pomerantz Mark, Freedman Matthew L, Lee Gwo-Shu Mary, Kantoff Philip |
| Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Sep 20 (9): 1937-43. Ahern Thomas P, Christensen Mariann, Cronin-Fenton Deirdre P, Lunetta Kathryn L, Søiland Håvard, Gjerde Jennifer, Garne Jens Peter, Rosenberg Carol L, Silliman Rebecca A, Sørensen Henrik Toft, Lash Timothy L, Hamilton-Dutoit Steph |
| Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clinical pharmacology and therapeutics 2011 May 89 (5): 708-17. Mürdter T E, Schroth W, Bacchus-Gerybadze L, Winter S, Heinkele G, Simon W, Fasching P A, Fehm T, , Eichelbaum M, Schwab M, Brauch |
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.
PLoS genetics 2012 Jul 8 (7): 7. Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimäki T, Keildson S, Lunetta KL, He C, Fornage M, Lagou V, Mangino M, Onland-Moret NC, Chen B, Eriksson J, Garcia M, Liu YM, Koster A, Lohman K, Lyytikäinen LP, Petersen AK, Prescott J, Stolk L, Vandenput L, Wood AR, Zhuang WV, Ruokonen A, Hartikainen AL, Pouta A, Bandinelli S, Biffar R, Brabant G, Cox DG, Chen Y, Cummings S, Ferrucci L, Gunter MJ, Hankinson SE, Martikainen H, Hofman A, Homuth G, Illig T, Jansson JO, Johnson AD, Karasik D, Karlsson M, Kettunen J, Kiel DP, Kraft P, Liu J, Ljunggren O, Lorentzon M, Maggio M, Markus MR, Mellström D, Miljkovic I, Mirel D, Nelson S, Morin Papunen L, Peeters PH, Prokopenko I, Raffel L, Reincke M, Reiner AP, Rexrode K, Rivadeneira F, Schwartz SM, Siscovick D, Soranzo N, Stöckl D, Tworoger S, Uitterlinden AG, van Gils CH, Vasan RS, Wichmann HE, Zhai G, Bhasin S, Bidlingmaier M, Chanock SJ, De Vivo I, Harris TB, Hunter DJ, Kähönen M, Liu S, Ouyang P, Spector TD, van der Schouw YT, Viikari J, Wallaschofski H, McCarthy MI, Frayling TM, Murray A, Franks S, Järvelin MR, de Jong FH, Raitakari O, Teumer A, Ohlsson C, Murabito JM, Perry JR |
| Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk. Genetic testing and molecular biomarkers 2013 Jan 17 (1): 3-9. Grant Delores J, Hoyo Cathrine, Oliver Shannon D, Gerber Leah, Shuler Katie, Calloway Elizabeth, Gaines Alexis R, McPhail Megan, Livingston Jonathan N, Richardson Ricardo M, Schildkraut Joellen M, Freedland Stephen |
| Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients. PloS one 2013 8 (8): e72219. Markiewicz Aleksandra, We?nicka-Ja?kiewicz Marzena, Skokowski Jaros?aw, Ja?kiewicz Janusz, Szade Jolanta, Jassem Jacek, Zaczek Anna |
| CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial. Breast cancer research and treatment 2013 Jul 140 (2): 363-73. Dezentjé V O, van Schaik R H N, Vletter-Bogaartz J M, van der Straaten T, Wessels J A M, Kranenbarg E M-K, Berns E M, Seynaeve C, Putter H, van de Velde C J H, Nortier J W R, Gelderblom H, Guchelaar H |
| Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study. BMC cancer 2013 13 (1): 556. Vidal Adriana C, Tucker Cocoa, Schildkraut Joellen M, Richardson Ricardo M, McPhail Megan, Freedland Stephen J, Hoyo Cathrine, Grant Delores |
| The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions. Genes, chromosomes & cancer 2014 Jun 53 (6): 454-66. Angstadt Andrea Y, Hartman Terryl J, Lesko Samuel M, Muscat Joshua E, Zhu Junjia, Gallagher Carla J, Lazarus Phil |
| Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Genes, chromosomes & cancer 2014 Jul 53 (7): 568-78. Scherer Dominique, Koepl Lisel M, Poole Elizabeth M, Balavarca Yesilda, Xiao Liren, Baron John A, Hsu Li, Coghill Anna E, Campbell Peter T, Kleinstein Sarah E, Figueiredo Jane C, Lampe Johanna W, Buck Katharina, Potter John D, Kulmacz Richard J, Jenkins Mark A, Hopper John L, Win Aung K, Newcomb Polly A, Ulrich Cornelia M, Makar Karen |
| Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. PloS one 2015 10 (7): e0132269. Romero-Lorca Alicia, Novillo Apolonia, Gaibar María, Bandrés Fernando, Fernández-Santander A |
| Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients. World journal of surgery 2015 Oct . Agarwal Gaurav, Tulsyan Sonam, Lal Punita, Mittal Balr |
| Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical pharmacokinetics 2016 Apr . Sutiman Natalia, Lim Joanne Siok Liu, Muerdter Thomas E, Singh Onkar, Cheung Yin Bun, Ng Raymond Chee Hui, Yap Yoon Sim, Wong Nan Soon, Ang Peter Cher Siang, Dent Rebecca, Schroth Werner, Schwab Matthias, Khor Chiea Chuen, Chowbay Balr |
| Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms. Xenobiotica; the fate of foreign compounds in biological systems 2016 Mar 1-10. Street Christina M, Zhu Zhaohui, Finel Moshe, Court Michael |
| Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study. Gene 2017 Sep . Habibi Mohsen, Mirfakhraie Reza, Khani Maryam, Rakhshan Azadeh, Azargashb Eznollah, Pouresmaeili Farkhond |
| Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis. Oncotarget 2017 (32): 52837-52845. Zhong Xiao, Feng Jiayu, Xiao Ya, Wang Pingxian, Fan Qiming, Wu Ronghua, Hu Wengang, Huang Chibi |
| Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2017 Dec . Tang Li, Platek Mary E, Yao Song, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Wu Yue, Platz Elizabeth A, Neuhouser Marian L, Stanczyk Frank Z, Reichardt Juergen K V, Santella Regina M, Hsing Ann, Figg William D, Lippman Scott M, Thompson Ian M, Ambrosone Christine |
| CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients. Cancers 2019 9 11 (9): . Ahmed Jemal Hussien, Makonnen Eyasu, Fotoohi Alan, Aseffa Abraham, Howe Rawleigh, Aklillu Ele |
| UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data. Annals of human biology 2019 1 45 (6-8): 516-523. Novillo Apolonia, Gaibar María, Romero-Lorca Alicia, Chaabani Hassen, Amir Nadir, Moral Pedro, Esteban M Esther, Fernández-Santander A |
| Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in pharmacology 2021 12 12 661443. Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis |
| Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia. PloS one 2021 16 (1): e0245362. Boujemaa Maroua, Hamdi Yosr, Mejri Nesrine, Romdhane Lilia, Ghedira Kais, Bouaziz Hanen, El Benna Houda, Labidi Soumaya, Dallali Hamza, Jaidane Olfa, Ben Nasr Sonia, Haddaoui Abderrazek, Rahal Khaled, Abdelhak Sonia, Boussen Hamouda, Boubaker Mohamed Sam |
| Allelic variants in xenobiotic metabolism genes predict susceptibility and worse prognosis of urothelial bladder cancer. Pathology, research and practice 2024 12 266 155767. Isabely Mayara da Silva, Flora Troina Maraslis, Julia Ayumi Ikeda Kawasaki, Natieli Kazue Aida, Gustavo Rafael Mazzaron Barcelos, Alexsandro Koike, Paulo Emílio Fuganti, Ilce Mara de Syllos Cólus, Roberta Losi Guembarovski, Juliana Mara Serpelo |
- Page last reviewed:Feb 1, 2024
- Content source: